Hypogonadism
📧 Sign up to get email alerts when something new happens for Hypogonadism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-02-28FDA Approved: TESTOSTERONE — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved an original ANDA for a generic testosterone product manufactured by Padagis Israel Pharmaceuticals Ltd. This approval enabl…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: TOM: Testosterone in Older Men With Sarcopenia [Phase 4]
The TOM Phase 4 trial evaluating testosterone in older men with sarcopenia was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Efficacy of Fenugreek Seed and Lespedeza Cuneata in TDS [Phase 4]
Phase 4 trial assessing the efficacy of fenugreek seed and Lespedeza cuneata for hypogonadism has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Anastrozole Administration in Elderly Hypogonadal Men [Phase 2]
Phase 2 trial update on anastrozole administration in elderly men with hypogonadism; results posted after completion.
-
FDA approval · 2017-01-25FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for testosterone cypionate from Padagis US LLC, authorizing changes related to this generic product …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-01-25Clinical Trial Update: Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation
This update reports the development and validation of in vitro cell-based bioassays for nuclear receptor activation, with relevance to hypog…
-
CLINICAL_TRIALS withdrawal · 2017-01-19Clinical Trial Update: Androgen Regulation of Priapism in Sickle Cell Disease [EARLY_Phase 1]
This document announces the withdrawal of an early-phase trial investigating androgen regulation of priapism in sickle cell disease.
-
FDA approval · 2016-10-25FDA Approved: TESTIM — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for TESTIM (testosterone gel) from Endo USA, Inc., signaling an updated/expanded labeling for testos…
-
FDA approval · 2016-10-25FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for testosterone cypionate by Sun Pharmaceutical Industries, typically indicating updated labeli…
-
FDA approval · 2016-10-25FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Hospira's testosterone cypionate, updating its approval status under the supplemental pathway.
-
FDA label_change · 2016-10-25FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)
The FDA approved a supplemental application for ANDROGEL (testosterone) from ASCEND Therapeutics U.S., LLC.
-
FDA approval · 2016-10-25FDA Approved: AVEED — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for AVEED (testosterone undecanoate) from Endo USA, Inc., expanding or modifying its regulatory appr…
-
FDA approval · 2016-10-25FDA Approved: VOGELXO — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for VOGELXO (testosterone) from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2016-10-25FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for testosterone cypionate from Padagis US LLC, approving a change to the approved generic product.
-
FDA approval · 2016-10-25FDA Approved: NATESTO NASAL GEL — Supplemental Application (Acerus Pharmaceuticals Corporation)
FDA approved a supplemental application for NATESTO nasal gel (testosterone) from Acerus Pharmaceuticals Corporation.
-
FDA approval · 2016-10-25FDA Approved: TESTOSTERONE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for testosterone submitted by Prasco Laboratories, finalizing an update to the product labeling.
-
FDA approval · 2016-10-14FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for TESTOSTERONE CYPIONATE from Sun Pharmaceutical Industries, updating the status of the approved g…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Bone Density and Serum Testosterone in Male Methadone Maintained Patients
A completed clinical trial evaluating bone density and serum testosterone in men on methadone maintenance therapy. The study addresses osteo…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Completed clinical trial examining whether hormone levels and sexual function can predict outcomes in men with diabetes following coronary r…
-
FDA approval · 2016-08-01FDA Approved: TESTOPEL — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for TESTOPEL (testosterone) from Endo USA, Inc., updating the product labeling under an approved…
-
FDA approval · 2016-07-26FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Padagis US LLC)
FDA approves a supplemental application for testosterone cypionate from Padagis US LLC, resulting in FDA-approved labeling for the generic p…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors
A completed clinical trial from Rigshospitalet, Denmark, examining symptoms and clinical signs of hypogonadism in testicular cancer survivor…
-
CLINICAL_TRIALS research · 2016-07-07Clinical Trial Update: Association Between Testosterone Levels and COPD Severity
A clinical trial update examining the association between testosterone levels and chronic obstructive pulmonary disease severity; no results…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Evaluation of Furosap in Human Volunteers [NA]
A completed clinical trial evaluating Furosap in human volunteers for hypogonadism.
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Oral Testosterone for the Treatment of Hypogonadism in Males [Phase 2]
A Phase 2 trial evaluating oral testosterone for hypogonadism in males has completed, with results posted on May 30, 2016.